FDA NDC Directory · JSON-LD · Markdown

KENGREAL

NDC 10122-620 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namecangrelor
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA204958
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsCANGRELOR (50 mg/1)
Marketing started20150708
Package count1

External sources

Source: openFDA. Public-domain (CC0).